Table 1 Baseline clinical characteristics of patients
Variable | CABG | PCI | P value |
|---|---|---|---|
(n = 355) | (n = 342) | ||
Age (mean ± SD) | 61.68 ± 8.9 | 61.42 ± 10.6 | 0.720 |
EF | 0.474 ± 0.07 | 0.490 ± 0.09 | 0.002 |
EF (< 0.40), n(%) | 38 (11.38) | 22 (12.43) | 0.722 |
Male, n (%) | 186 (55.7) | 98 (52.9) | 0.552 |
Hypertension, n (%) | 200 (59.8) | 116 (62.7) | 0.527 |
Hyperlipidemia, n (%) | 143 (42.81) | 85 (45.95) | 0.491 |
Smoking, n (%) | 71 (21.26) | 24 (24.32) | 0.424 |
Peripheral vascular disease (%) | 49 (14.67) | 10 (5.41) | 0.001 |
MI history, n (%) | 82 (24.55) | 42 (22.70) | 0.635 |
Stroke history, n (%) | 9 (2.69) | 3 (1.62) | 0.423 |
LAD involvement, n (%) | 334 (100) | 161 (87.3) | < 0.001 |
Treated vessel territory, n (%) | |||
 RCA | 258 (77.25) | 67 (36.22) | < 0.001 |
 LAD | 319 (95.51) | 116 (62.70) | < 0.001 |
 LCX | 238 (71.26) | 49 (26.49) | < 0.001 |
LV function, n (%) | |||
 Mild | 160 (42.90) | 51 (27.57) | < 0.001 |
 Moderate | 27 (8.08) | 12 (6.49) | |
 Severe | 9 (2.69) | 9 (4.86) | |
 Normal | 138 (41.32) | 113 (61.08) | |
 Treated/untreated diabetes | 308 (92.22) | 160 (86.49) | 0.039 |
Treatment of diabetes | |||
 Insulin | 52 (14.6) | 39 (11.4) | 0.397 |
 Oral drug | 191 (53.8) | 180 (52.6) | |
 Dietary | 83 (23.4) | 86 (25.1) | |
 Nothing | 29 (8.2) | 37 (10.8) | |
 Aspirin (%) | 349(98.3) | 340 (99.4) | 0.171 |
 Clopidogrel (%) | 301(84.8) | 328 (95.9) | < 0.001 |
No. of disease vessels, n (%) | |||
 One vessel disease | 21 (5.9) | 157 (45.9) | < 0.001 |
 Two vessel disease | 77 (21.7) | 141 (41.2) | |
 Three vessel disease | 257 (72.39) | 44 (12.87) | |
Number of stent/graft per patient, n (%) | |||
 1 | 33 (9.30) | 261 (76.32 |  |
 2 | 105 (29.58) | 73 (21.35) | |
 3 | 171 (48.17) | 8 (2.34) | |
 4 | 44 (12.39) | 0 (0%) | |
 5 | 2 (.56) | 0 (0%) | |